Cardiometabolic Medicine
The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia. These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.
Our Tweetorials
Your new source for free CE/CME via Twitter!
Each program provides 0.5hr – 1.0hr credit for physicians, pharmacists, and nurses.
JOURNAL CLUB: Delphi Panel on Management of Life-Threatening DOAC-Associated GI Bleed
2a) 2⃣ very cool aspects of this work: first, it's truly #multidisciplinary, with international authors from #emergencymedicine,...
What Every Non-Cardiologist Should Know About ATTR-CM: A Primer
2) Our expert author is Ronald Witteles MD @Ron_Witteles, @StanfordMed IM program director, Professor of Medicine, #Cardiologist, Specialist in...
Early Rhythm Control to Improve Outcomes in Patients with Atrial Fibrillation
2) This program is intended for #healthcare providers & is supported by an independent educational grant from Sanofi. Statement of accreditation...
LATE-BREAKING DATA FROM WSC2023: TOP-LEVEL RESULTS FROM ANNEXa-I TO INFORM CHOICE OF REVERSAL STRATEGY IN DOAC-ASSOCIATED ICH
2) Our expert author is #ANNEXa_I investigator Ashkan Shoamanesh MD @Ash_Shoamanesh, #Stroke #Neurologist @HamHealthSci, Assoc Prof @McMasterU,...
SUPPORTING HEMOSTASIS IN ANTI-FXa-ASSOCIATED INTRACRANIAL HEMORRHAGE: UPDATE FROM WSC2023
2) Your faithful correspondent and faculty is #emergencymedicine specialist and #thrombosis researcher Charles Pollack MD @md_pollack from...
Current Data and Guidelines for Safe and Well-Managed Anticoagulation in Cancer-Associated Thrombosis
1b) Our expert co-faculty are Tzu-Fei Wang MD @TzufeiWang, #thrombosis & benign #shematologist from @OttawaHospital and Alok Khorana MD @aakonc,...
Analyzing Safety Data for siRNA for Lowering LDL-C and Lp(a)
1b) @lipiddoc is a #lipidologist🩺🧬@nyulangone @NYUCVDPrevent. He is President of the Foundation of @nationallipid, Past-President of both...
Recent Advances in Risk Assessment in Patients with Hyperlipidemia: Enhancing Precision and Reliability
2) This presentation was originally delivered by @NP_ltl_a at an accredited satellite symposium at @nationallipid's June 2023 congress. She...
Comparing In-Hospital Mortality with Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate
1b) Follow this 🧵to earn 0.5hr 🆓 CE/#CME on your only source for expert-authored #MedEd in the #cardiometabolic space delivered wholly on X--or...
Understanding the Limitations and Inconveniences of Current Approaches to CAT Management
2) The program is supported by an unrestricted educational grant from Anthos Therapeutics. Statement of accreditation & faculty disclosures at...
@Cardiomet_CE on Twitter
Your only source for ACCREDITED SoMe-delivered
serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!
On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr – 1.0hr CE/CME. Programs are presented by expert faculty in engaging and fully interactive format. Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.